
$PVCT on Substack: The Building Before the Hoped-for Inflection Point ... provectus.substack.com/p/the… … #RoseBengal #RoseBengalSodium #BiotechInnovation #SmallMolecule

We are a clinical-stage biotech developing immunotherapy medicines for different diseases based on lead synthetic small molecule rose bengal sodium.

$PVCT on Substack: The Building Before the Hoped-for Inflection Point ... provectus.substack.com/p/the… … #RoseBengal #RoseBengalSodium #BiotechInnovation #SmallMolecule

$PVCT on Substack: Pharma’s Cancer Drugs are Its Business Model ... provectus.substack.com/p/pha… ... #RoseBengalSodium #RoseBengal #BiotechInnovation #HealthcareInnovation #SmallMolecule #Oncology

$PVCT on Substack: Provectus Update: Ophthalmology, Oncology, and the Theory of Treating Cancer Behind Rose Bengal Sodium Science ... provectus.substack.com/p/pro… ... #RoseBengalSodium #RoseBengal #BiotechInnovation #HealthcareInnovation #SmallMolecule #VisiRose #Oncology #Ophthalmology #Neurology #dermatology

$PVCT on Substack: VisiRose at ESCRS iNovation Day 2026 ... provectus.substack.com/p/vis… ... #RoseBengalSodium #RoseBengal #BiotechInnovation #HealthcareInnovation #SmallMolecule #VisiRose #Ophthalmology

$PVCT on Substack: From an In-Office Procedure to a Bedtime Drop: Inside Provectus’s and VisiRose’s New Eye Care Patent ... provectus.substack.com/p/fro… ... #RoseBengalSodium #RoseBengal #BiotechInnovation #HealthcareInnovation #SmallMolecule #VisiRose #Ophthalmology

#VisiRose Selected to Present RB-PDAT at ESCRS iNovation® Day 2026 Emerging Company Showcase ... globenewswire.com/news-relea… ... $PVCT #RoseBengal #RoseBengalSodium #BiotechInnovation #Ophthalmology

$PVCT on Substack: Why Provectus Biopharmaceuticals Is Giving Away Its Most Valuable Molecule — On Purpose ... provectus.substack.com/p/why… #RoseBengalSodium #BiotechInnovation #HealthcareInnovation #SmallMolecule #VeripureTM

$PVCT on #LinkedIn: One Molecule, Two Kingdoms: What a Mustard Plant Reveals About Provectus’s Rose Bengal Sodium ... linkedin.com/pulse/one-molec… … #RoseBengal #RoseBengalSodium #BiotechInnovation

Independent University of Lille Study Shows Rose Bengal Sodium Produces Opposing Mechanistic Effects at the Same Dose $PVCT globenewswire.com/news-relea… #RoseBengal #RoseBengalSodium #BiotechInnovation #SmallMolecule

$PVCT on Substack: Provectus's 2026 Annual Stockholder Meeting ... provectus.substack.com/p/pro… #RoseBengalSodium #BiotechInnovation #SmallMolecule

$PVCT and #VisiRose Announce U.S. Patent Award for Light-Independent Antibacterial Eye Drop Targeting Drug-Resistant Ocular Infections globenewswire.com/news-relea… #RoseBengal #RoseBengalSodium #BiotechInnovation #Ophthalmology

$PVCT Launches Veripure™, an Open Science Program for Medical Research Access to PV-10 (rose bengal sodium) globenewswire.com/news-relea… #RoseBengal #RoseBengalSodium #BiotechInnovation #SmallMolecule

$PVCT on Substack: Provectus Announces Investor Webinar of 2026 Annual Meeting for June 18th at 4 pm ET ... provectus.substack.com/p/pro… #RoseBengalSodium #BiotechInnovation #SmallMolecule

$PVCT Announces Investor Webinar for 2026 Annual Meeting of Stockholders globenewswire.com/news-relea… #RoseBengal #RoseBengalSodium #BiotechInnovation #SmallMolecule #AnnualMeeting

$PVCT on Substack: Oral PV-10 Wins. Here’s the Scorecard of Provectus’s Preclinical Bladder Cancer Study. ... provectus.substack.com/p/ora… … #RoseBengal #RoseBengalSodium #BiotechInnovation #SmallMolecule #Oncology #BladderCancer

$PVCT Reports Oral PV-10 Anti-Tumor Activity in Preclinical Bladder Cancer Study; Long-Term Survivors Show Absence of Gross Bladder Tumor at Study End globenewswire.com/news-relea… #rosebengal #rosebengalsodium #Biotech #HealthcareInnovation #Oncology #BladderCancer